1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Ameloblastoma: new trials by email Literature Review of Ameloblastoma trials Research Report on Ameloblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF V600E-Mutated Ameloblastoma Dabrafenib and trametinib (combination) - Ameloblastoma | Phase 2 / Phase 3 | Not yet recruiting | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 46 | 2025-03-01 | 2025-02-11 |
| Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma Dabrafenib, Trametinib - Ameloblastoma, BRAF V600E Mutation Positive | Phase 2 | Recruiting | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 12 | 2023-01-01 | 2024-10-22 |
| Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma Dabrafenib, Trametinib - Ameloblastoma, BRAF Gene Mutation | Phase 2 | Completed | Stanford University | 1 | 2017-07-17 | 2024-01-30 |
Adamantinoma (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Odontogenic Tumors (3) · Bone Diseases (1) · Bone Neoplasms (1) · Musculoskeletal Diseases (1) · Neoplasms by Site (1)
dabrafenib (3) · trametinib (3)
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (2) · Stanford University (1)
China (1) · United States (1)